Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Dimitrios Kapogiannis MD

Dimitrios Kapogiannis MD

Investigator, Laboratory of Clinical Investigation, National Institute on Aging, National Institutes of Health, Baltimore, Maryland
Dimitrios Kapogiannis is an Investigator at the National Institute on Aging and Adjunct Associate Professor at the Department of Neurology at Johns Hopkins University. His research focuses on biomarker development using plasma exosomes and clinical studies of metabolic interventions in Alzheimer’s disease.


Dr. Kapogiannis has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Donanemab in Early Alzheimer's Disease